Example: Heart Attack

Search clinical trials for: Dose decrease

Total 7779 results

NCT07491471

Withdrawn

Clinican BEAD-T1D: Building the Evidence to Address Disengagement in Type 1 Diabetes (BEAD-T1D)

Type 1 Diabetes (T1D)
NCT03053336

Completed

App-technology to Increase Physical Activity Among Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus | Exercise
NCT03244891

Completed

Autonomic Challenges From Mild Hypovolemia and Mechanical Ventilation

Hypovolemia | Autonomic Nervous System Imbalance | Positive-Pressure Respiration
NCT03798873

Unknown

Impact of the Use of FeelWell™ Compression Garment on Individuals With a BMI ≥35

Quality of Life | Obesity | Back Pain | Exercise | Body Composition | Obesity, Abdominal | Pain, Chronic | Mobility Limitation | Weight Change, Body | Inactivity
NCT01057030

Completed

Multiple Dose Japanese Bridging Study

Alzheimer Disease
NCT07166796

Completed

a Phase I PK Study in Healthy Male Subjects. 2 Groups of Healthy Male Subjects

Health Subjects
NCT00254150

Completed

A Therapy to Reduce Morbidity and Hospital Length of Stay of High-Risk Surgical Patients

High-Risk Surgical Patients
NCT03868566

Terminated

An Open-Label Study to Assess the Hepatic Protection Effect of SNP-612, in Patients With NAFLD

NASH - Nonalcoholic Steatohepatitis
NCT04157686

Completed

MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)

Lateral Canthal Lines | Glabellar Lines
NCT06464055

Recruiting

A Study of GQ1010 in Subjects With Advanced Solid Tumors

Advanced Malignant Solid Tumors
NCT06152757

Recruiting

BGT007H Cells for the Treatment of Recurrent/Refractory Gastrointestinal Tumors

Gastrointestinal Tumors
NCT05540860

Active, not recruiting

A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX) (LYNX)

Duchenne Muscular Dystrophy
NCT04002193

Completed

Pleth Variability Index in Modified Prone Position or Knee-chest Position (Concord Position)

Fluid Responsiveness | Modified Prone Position
NCT04557267

Completed

Dose-ranging Study of SKF7™ for Obesity

Obesity
NCT05227196

Completed

A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy People

Type 2 Diabetes | Healthy Volunteers
NCT07297160

Not yet recruiting

CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors (CALySSEY)

Sarcoma | Lymphoma | Kidney Cancer | Solid Tumors | Myeloma
NCT02368912

Completed

A Study to Assess the Safety, Tolerability and Effects of Single and Multiple Ascending Doses of ASP1707 in Healthy Male and Pre-menopausal Female Subjects, Including a Comparison of the Effects Under Fasted and Fed Conditions in Healthy Young Male Subjects

Pharmacokinetics of ASP1707 | Pharmacodynamics of ASP1707
NCT04427527

Completed

Accelerating Colorectal Cancer Screening Through Implementation Science in Appalachia (ACCSIS)

Colorectal Cancer
NCT02216968

Completed

Increasing Vegetable Intake in Children

Obesity | Behavior | Food Habits
NCT03097341

Completed

Safety and Tolerability Study of Xisomab 3G3 in Healthy Adult Subjects

Thrombosis
NCT06652529

Not yet recruiting

Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid Tumors (AROG4-01-01)

Ovarian Cancer | Mesothelioma | Colorectal Carcinoma | Solid Tumors (Phase 1) | NSCLC (Advanced Non-small Cell Lung Cancer)
NCT03998514

Completed

A Phase 1a/1b Study of CB4211 in Healthy Non-obese Subjects and Subjects With Nonalcoholic Fatty Liver Disease

Nonalcoholic Fatty Liver Disease
NCT02956499

Completed

Study to Assess Safety, Tolerability and Pharmacokinetics of APX001 Administered by Intravenous Infusion to Healthy Subjects

Fungal Infection
NCT01740609

Completed

A Study To Assess The Safety Of PF-06342674 In Healthy Volunteers

Healthy
NCT07615985

Not yet recruiting

A Study to Test the Safety and Blood Levels of PMG1016 in Healthy Adults

Chronic Kidney Disease
NCT07502638

Not yet recruiting

FXS6837 for the Treatment of IgAN Patients

IgAN
NCT07140614

Recruiting

A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A.

Charcot-Marie-Tooth Disease, Type 1A
NCT05655299

Terminated

VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis (Serenity PsO)

Psoriasis
NCT05984134

Completed

Efficacy and Safety Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction

Acute Myocardial Infarction
NCT06918366

Active, not recruiting

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Inhaled XQ-001 in Healthy Subjects

Healthy
NCT04464889

Withdrawn

HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplantation

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Myeloproliferative Disorders | Multiple Myeloma | Myelofibrosis | Chronic Myeloid Leukemia | Acute Lymphoid Leukemia | Malignant Lymphoma
NCT04019561

Completed

A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH.

Non-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)
NCT04664504

Recruiting

A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk

Rectal Cancer
NCT05038644

Terminated

XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia

Acute Myeloid Leukemia | T Cell Lymphoblastic Lymphoma | T Cell Acute Lymphoblastic Leukemia
NCT04835727

Completed

Effect of Semi-vegetarian Diet in Inflammatory Bowel Disease Patients With Clinical Remission

Inflammatory Bowel Diseases | Fecal Microbiota | Calprotectin | Vegetarian Diet
NCT05003531

Completed

A Study to Evaluate IBI112 in the Treatment of Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis
NCT03001297

Completed

Phase 1, Single Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of MEDI5884

Healthy Volunteers
NCT00980200

Completed

Efficacy and Safety Study in Subjects With Asthma

Asthma
NCT06391827

Completed

A Study to Evaluate Safety, Tolerability, and PK of DA-7503 in Healthy Adult and Elderly Participants

Healthy
NCT03214614

Completed

A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2451 in Healthy Male Subjects

Healthy
NCT00507520

Completed

Almond Dose Response Study.

Cardiovascular Disease | Hyperlipidemia | Diet Therapy
NCT04631107

Completed

AD109 Dose Finding in Mild to Moderate OSA

Obstructive Sleep Apnea
NCT07227857

Recruiting

A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy (KANDLE)

Epileptic Encephalopathy
NCT05151133

Recruiting

Clinical Study of Allergic Rhinitis Therapy by Stem Cells

Allergic Rhinitis
NCT03784365

Unknown

Single-Versus Multiple-dose Antimicrobial Prophylaxis for Peroral Endoscopic Myotomy in Achalasia (SMAPP)

Achalasia Cardia
NCT01881295

Completed

Bioavailability of Potassium From Potatoes and Potassium Gluconate (Potato)

Blood Pressure | Potassium Bioavailability
NCT01007019

Completed

Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH4808 After Oral Administration in Healthy Male Subjects

Healthy
NCT01385566

Completed

A Study of Intradermal Administration of ZOSTAVAX™ (V211-051 AM2)

Herpes Zoster
NCT07535866

Completed

Remote Step Rate and Load Based Interventions in Runners With Patellofemoral Pain

Patellofemoral Pain, PFP
NCT02388347

Completed

A Study to Assess the Safety of MEDI7836 in Healthy Adults.

Healthy Adults

Search clinical trials for: Dose decrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations